Evariste

London, United Kingdom

Evariste discovers novel synthetic lethal oncology targets and designs small molecule therapeutics using its AI-enabled platform, Frobenius.

$4.0M raised

Jan 2024

Seed

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Evariste

How much funding has Evariste raised?

Evariste has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Where is Evariste headquartered?

Evariste is headquartered in London, United Kingdom.

What does Evariste do?

Evariste discovers novel synthetic lethal oncology targets and designs small molecule therapeutics using its AI-enabled platform, Frobenius.

What stage is Evariste at?

Evariste is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2024.

MLA

"Evariste — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/evariste. Accessed June 17, 2026.

APA

VCBacked. (2024). Evariste — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/evariste

Wikipedia (cite web)

{{cite web |title=Evariste — Funding & Investors |url=https://www.vcbacked.co/company/evariste |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2024.